Head-to-Head Comparison
| Criteria | Boswellia | Curcumin | Winner |
|---|---|---|---|
| Short-Term Pain Reduction (Osteoarthritis) | Strong -- effect size >0.80 | Strong -- effect size >0.80 | Tie |
| Mechanism of Action (Inflammation) | Strong -- inhibits 5-LOX enzyme | Moderate -- general anti-inflammatory properties | Boswellia |
| Long-Term Efficacy (Osteoarthritis) | Weak -- no clinically important effects at long-term follow-up | Weak -- no clinically important effects at long-term follow-up | Tie |
| Clinical Utility in Knee OA Management | Moderate -- effective adjunct for knee OA pain | Moderate -- effective adjunct for knee OA pain | Tie |
| Standardization and Potency | Strong -- requires AKBA and ≥30% boswellic acids | Moderate -- efficacy depends on bioavailability | Boswellia |